Literature DB >> 6172211

Antiviral agents for the control of viral diseases.

G J Galasso.   

Abstract

Infectious viral diseases are an important worldwide problem and as a result of more efficient epidemiological studies and improved techniques of viral diagnosis "new" diseases are periodically identified. More importantly, as we learn to control cancer and perform tissue and organ transplants, the immunosuppressed patient is at greater risk of viral infection. There are currently very few generally accepted antiviral agents, but recent research efforts are encouraging. The status of the approved agents and of those showing the greatest promise is discussed in this article.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172211      PMCID: PMC2396087     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Herpes simplex encephalitis: vidarabine therapy and diagnostic problems.

Authors:  R J Whitley; S J Soong; M S Hirsch; A W Karchmer; R Dolin; G Galasso; J K Dunnick; C A Alford
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

Review 2.  Antiviral agents as adjuncts in cancer chemotherapy.

Authors:  W M Shannon; F M Schabel
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

3.  Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection.

Authors:  C B Smith; R P Charette; J P Fox; M K Cooney; C E Hall
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

4.  Prevention of Russian influenza by amantadine.

Authors:  A S Monto; R A Gunn; M G Bandyk; C L King
Journal:  JAMA       Date:  1979-03-09       Impact factor: 56.272

5.  Vidarabine therapy of neonatal herpes simplex virus infection.

Authors:  R J Whitley; A J Nahmias; S J Soong; G G Galasso; C L Fleming; C A Alford
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

  5 in total
  1 in total

1.  Chapter 3 Antiviral drugs: general considerations.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.